1. Market Research
  2. > Pathology Industry

rheumatoid arthritis Industry, February 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, Disease Management, Diagnostic Test, Biosimilar, Pharmaceutical, Stem Cell, Therapeutics, Therapy, Antibody, Clinical Trial, Company Sales Figures, Monoclonal Antibody, Sports Medicine.


 
1-10 of 76 reports for Rheumatoid Arthritis

Purchase Reports From Reputable Market Research Publishers

Global Rheumatoid Arthritis Partnering 2010 to 2016

Global Rheumatoid Arthritis Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • February 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Systemic Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed ...

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Juvenile Rheumatoid Arthritis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

 Juvenile Rheumatoid Arthritis-Pipeline Insights, 2016

Juvenile Rheumatoid Arthritis-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Juvenile Rheumatoid Arthritis-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Juvenile Rheumatoid ...

Rheumatoid Arthritis - Pipeline Review, H2 2015

Rheumatoid Arthritis - Pipeline Review, H2 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Markets Direct

Rheumatoid Arthritis - Pipeline Review, H2 2015 Summary Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H2 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic ...

NPS+ Rheumatoid Arthritis (EU5)

NPS+ Rheumatoid Arthritis (EU5)

  • $ 2 668
  • Industry report
  • December 2015
  • by Firstword Pharma

RA Drug Manufacturers: How Does Brand Loyalty Affect Your Market Share? Are European rheumatologists satisfied with the rheumatoid arthritis (RA) treatments on the market? How loyal are they to you ...

NPS+ Rheumatoid Arthritis (US)

NPS+ Rheumatoid Arthritis (US)

  • $ 2 668
  • Industry report
  • December 2015
  • by Firstword Pharma

RA Drug Manufacturers: How Does Brand Loyalty Affect Your Market Share? Are US rheumatologists satisfied with the rheumatoid arthritis (RA) treatments on the market? How loyal are they to your brand? ...

Medical Affairs Reputations (EU5): Rheumatoid Arthritis

Medical Affairs Reputations (EU5): Rheumatoid Arthritis

  • $ 7 370
  • Industry report
  • November 2015
  • by Firstword Pharma

Is your rheumatoid arthritis Medical Affairs team leading the pack or following behind?  How well are the Medical Affairs teams from biosimilar manufacturers performing when compared with those from ...

Medical Affairs Reputations (US): Rheumatoid Arthritis

Medical Affairs Reputations (US): Rheumatoid Arthritis

  • $ 7 370
  • Industry report
  • November 2015
  • by Firstword Pharma

Is your rheumatoid arthritis Medical Affairs team leading the pack or following on behind? How are Medical Affairs teams from challenger brands shaping up when compared with those from well-established ...

About 2 200 reports for Rheumatoid Arthritis

Download Unlimited Documents from Trusted Public Sources

Pathology Description

  • January 2014
    12 pages
  • Obesity  

    Arthritis  

View report >

Us - Economic Analysis

November 2013

Economic Analysis

January 2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.